Role of azithromycin against clinical isolates of family enterobacteriaceae: A comparison of its minimum inhibitory concentration by three different methods

Indian Journal of Medical Microbiology

Volumn 27, Issue 2, 2009, Pages 107-110

  Chayani, N ^a   Tiwari, S ^a   Sarangi, G ^a   Mallick, B ^a   Mohapatra, A ^a   Paty, B ^a   Das, P ^a  

^a SCB MEDICAL COLLEGE   (India)

Author keywords

Azithromycin; Enterobacteriaceae; Minimum inhibitory concentration determination

Indexed keywords

AGAR; AZITHROMYCIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITROBACTER; COMPARATIVE STUDY; CONTROLLED STUDY; DILUTION; DISK DIFFUSION; DRUG SENSITIVITY; ENTEROBACTERIACEAE; EPSILOMETER TEST; ESCHERICHIA COLI; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA; SENSITIVITY ANALYSIS; SHIGELLA;

EID: 65449165685     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.45361     Document Type: Article

References (15)

1. Murray BE. Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis 1986;8:S172-81.
2. Murray BE. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J Infect Dis 1991;163:1185-94.
3. Andremont A., Raibaud P, Tancrede C. Effect of erythromycin on microbial antagonisms: A study in gnotobiotic mice associated with a human fecal flora. J Infect Dis 1983;148:579-87.
4. Gordillo ME, Singh KV, Murray BE. In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother 1993;37:1203-5.
5. Butler T, Girard AE. Comparative efficacies of azithromycin and Ciprofloxacin against experimental Salmonella typhimurium infection in mice. J Antimicrob Chemother 1993;31:313-9.
6. th ed. St. Louis: Mosby Company; 2002. p. 133-47.
7. th ed. Mosby Company; St. Louis: 2002. p. 148-61.
8. Wildfeuer A, Laufen H, Zimmermann T. Uptake of azithromycin by various cells and its intracellular activity under in-vivo conditions. Antimicrob Agents Chemother 1996;40:75-9.
9. Pascual A, Conejo MC, García I, Perea EJ. Factors affecting the intracellular accumulation and activity of azithromycin. J Antimicrob Chemother 1995;35:85-93.
10. Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhria R, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999;44:243-50.
11. Gordillo ME, Singh KV, Murray BE. In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother 1993;37:1203-5.
12. Beilei GE, Bodeis S, Walker RD, White DG, Zhao S, McDermott PF, et al. Comparison of the E-test and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter. J Antimicrob Chemother 2002;50:487-94.
13. Steward CD, Stocker SA, Swenson JM, O'Hara CM, Edwards JR, Gaynes RP, et al. Comparison of agar dilution, disk diffusion, microscan, and vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluroquinolone: Resistant isolates of the family enterobacteriaceae. J Clin Microbiol 1999;37:544-7.
14. Mirza SH, Beeching NJ, Hart CA. Multi-drug resistant typhoid: A global problem. J Med Microbiol 1996;44:317-9.
15. Coovadia YM, Gathiram V, Bhamjee A, Garratt, RM, Mlisana K, Pillay N, et al. An outbreak of multiresistant Salmonella typhi in South Africa. Q J Med 1992;82:91-100.